Skip to main content
Industry Resources
Displaying 145 - 156 of 465
Display:
12
24
48
Immune-Mediated and Cholestatic Diseases
CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion" (Complete Session)
Webcasts
View
General Hepatology
Securing the Correct Diagnosis of HRS-AKI
Webcasts
View
General Hepatology
Early Treatment of HRS-AKI in the High-Risk Patient
Webcasts
View
General Hepatology
Panel Discussion and Q&A
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Introduction
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Case Based Discussion on Biochemical Normalization
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Case Based Discussion on QOL/Pruritus
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Conclusion
Webcasts
View
Immune-Mediated and Cholestatic Diseases
What Is on the Horizon? Emerging Treatments
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Q&A and Close
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Chair’s Welcome and Introduction
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
…
Page
9
Page
10
Page
11
Page
12
Current page
13
Page
14
Page
15
Page
16
Page
17
…
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy